OBJECTIVE To test the feasibility and validity of the EQ-5D (a widely used generic (disease non-specific) quality of life (QoL) instrument which allows comparisons between different patient groups and ...
Background: There are no studies of autonomic function comparing Alzheimer’s disease (AD), vascular dementia (VAD), dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). Aims: To ...
The opioid crisis is a significant public health issue that has led to a rising number of overdose deaths over the past 25 years. Cue-induced drug craving leads to a high risk of relapse, which urged ...
Objectives: To determine the prevalence of dementia in people under the age of 65 in a large catchment area, and use these figures to estimate the number of younger people affected by dementia in the ...
Dr Massimo Zeviani, Division of Biochemistry and Genetics, Istituto Nazionale Neurologico “Carlo Besta”, Via Celoria 11, Milano 20133, Italy. AIM To contribute to the establishment of a rational ...
Background Staging of disease severity is useful for prognosis, decision-making and resource planning. However, no commonly used, validated staging system exists for amyotrophic lateral sclerosis (ALS ...
Background Lesion resolution is often observed in children with myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and asymptomatic lesions are less commonly reported in MOGAD ...
Correspondence to Dr Zhang-Yu Zou, Department of Neurology, Fujian Medical University Union Hospital, No. 29, Xinquan Road, Gulou District, Fuzhou, 350001, Fujian, China; pumczzy{at}gmail.com or ...
Correspondence to Hanneke Frederica Maria Rhodius-Meester, Alzheimer Center, VU University Medical Center, Amsterdam 1007 MB, The Netherlands; h.rhodius{at}vumc.nl Patients with dementia have a ...
Background Clinical response immediately after revascularisation therapy differs among patients. Although reperfusion is the deciding factor with respect to this dramatic response to revascularisation ...
Correspondence to: Professor P G E Kennedy Department of Neurology, University of Glasgow, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK; p.g.kennedyclinmed.gla.ac ...
Background: Paraneoplastic neurological syndromes (PNS) are defined by the presence of cancer and exclusion of other known causes of the neurological symptoms, but this criterion does not separate ...